We observed that SOX2 levels were increased in 27% of premalignant actinic keratosis (AK) and 35% of cSCC lesions, whereas SOX2 expression levels were low in normal skin (NS) (Fig. 5e, f). This evidence concerns the gene SOX2 and skin squamous cell carcinoma.